Healthcare & Life Sciences
Translate Bio
United Stateswww.translate.bio/
Translate Bio is a startup based in the United States, most recent round Acquired, 2 tracked investors.
Acquiredacquired
acquired
Stage
2013
Founded
2
Investors
About Translate Bio
Translate Bio is a company founded in 2013 headquartered in the United States. Translate Bio has been acquired. Brouky records 2 investors associated with the company.
Translate Bio was a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of medicines to treat diseases caused by protein or gene dysfunction. It focused on creating transformative treatments using its mRNA platform.
Explore Translate Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.